Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Taysha Gene Therapies, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   10-K10-K
Net income  -174.5-60.0
Depreciation and amortization   [+]0.50.0
Stock-based compensation  18.23.4
Change in working capital   [+]28.7-0.1
Other operating activities  10.126.0
Cash from operations  -117.0-30.7
   
Capital expenditures  -15.3-0.1
Other cash from investing  -6.3-9.0
Cash from investing  -21.6-9.1
   
Issuance of common stock, net   165.9
Other cash from financing  39.1125.2
Cash from financing  39.1291.1
   
Free cash flow  -132.3-30.8
        Per share (diluted)  ($3.52)($1.74)
   
Cash paid for interest  0.60.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy